TrialJournal of the International AIDS Society2022

Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).

Maggie Czarnogorski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.